In the BioHarmony Drug Report Database
Clindamycin
Cleocin (clindamycin) is a small molecule pharmaceutical. Clindamycin was first approved as Cleocin on 1982-01-01. It is used to treat acne vulgaris, actinomycetales infections, bacterial infections, bacterial vaginosis, and bacteroides infections amongst others in the USA.
Trade Name
|
Cleocin |
|---|---|
Common Name
|
clindamycin |
ChEMBL ID
|
CHEMBL1753 |
Indication
|
acne vulgaris, actinomycetales infections, bacterial infections, bacterial vaginosis, bacteroides infections, pneumocystis pneumonia, staphylococcal infections, streptococcal infections, toxoplasmosis |
Drug Class
|
Antibiotics (Streptomyces strains) |
Image (chem structure or protein)